This is the authors' abstract. We don't add key points for this paper.
The corpus luteum (CL) is a site of intense angiogenesis. Within a short period, this is followed either by controlled regression of the microvascular tree in the non-fertile cycle, or maintenance and stabilisation of the new vasculature a conceptual cycle. The molecular regulation of these diverse aspects is examined. The CL provides a unique model system in which to study the cellular and molecular regulation of angiogenesis. Vascular endothelial growth factor (VEGF) has been found to have a major role in the CL. By targeting its action at specific stages of the luteal phase in vivo by antagonists, profound inhibitory effects on luteal angiogenesis and function are observed.
Answers are grounded in this paper and cite their sources.
VEGF plays a major role in the intense angiogenesis of the corpus luteum, and its antagonism profoundly inhibits luteal angiogenesis and function.
No takes yet. Share an insight, caveat, or question.
Fraser et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: